Literature DB >> 32065346

Novel quinolinone-pyrazoline hybrids: synthesis and evaluation of antioxidant and lipoxygenase inhibitory activity.

Ioanna Kostopoulou1, Antonia Diassakou1, Eleni Kavetsou1, Eftichia Kritsi2, Panagiotis Zoumpoulakis2, Eleni Pontiki3, Dimitra Hadjipavlou-Litina3, Anastasia Detsi4.   

Abstract

The present project deals with the investigation of structure-activity relationship of several quinolinone-chalcone and quinolinone-pyrazoline hybrids, in an effort to discover promising antioxidant and anti-inflammatory agents. In order to accomplish this goal, four bioactive hybrid quinolinone-chalcone compounds (8a-8d) were synthesized via an aldol condensation reaction, which were then chemically modified, forming fifteen new pyrazoline analogues (9a-9o). All the synthesized analogues were in vitro evaluated in terms of their antioxidant and soybean lipoxygenase (LOX) inhibitory activity. Among all the pyrazoline derivatives, compounds 9b and 9m were found to possess the best combined activity, whereas 9b analogue exhibited the most potent LOX inhibitory activity, with IC50 value 10 μM. The in silico docking results revealed that the synthetic pyrazoline analogue 9b showed high AutoDock Vina score (- 10.3 kcal/mol), while all the tested derivatives presented allosteric interactions with the enzyme.

Entities:  

Keywords:  Antioxidant activity; Chalcones; LOX inhibition; Lipoxygenase; Pyrazolines; Quinolinones

Year:  2020        PMID: 32065346     DOI: 10.1007/s11030-020-10045-x

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  53 in total

Review 1.  Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate.

Authors:  A R Brash
Journal:  J Biol Chem       Date:  1999-08-20       Impact factor: 5.157

Review 2.  Treatment of asthma with antileukotrienes: first line or last resort therapy?

Authors:  Sven-Erik Dahlén
Journal:  Eur J Pharmacol       Date:  2006-02-28       Impact factor: 4.432

3.  Endogenous S-nitrosoglutathione modifies 5-lipoxygenase expression in airway epithelial cells.

Authors:  Khalequz Zaman; Marie H Hanigan; Alison Smith; John Vaughan; Timothy Macdonald; David R Jones; John F Hunt; Benjamin Gaston
Journal:  Am J Respir Cell Mol Biol       Date:  2006-01-13       Impact factor: 6.914

Review 4.  The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis.

Authors:  Katharina Lötzer; Colin D Funk; Andreas J R Habenicht
Journal:  Biochim Biophys Acta       Date:  2005-09-05

Review 5.  What are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis?

Authors:  G Fürstenberger; P Krieg; K Müller-Decker; A J R Habenicht
Journal:  Int J Cancer       Date:  2006-11-15       Impact factor: 7.396

Review 6.  5-Lipoxygenase: regulation of expression and enzyme activity.

Authors:  Olof Rådmark; Oliver Werz; Dieter Steinhilber; Bengt Samuelsson
Journal:  Trends Biochem Sci       Date:  2007-06-18       Impact factor: 13.807

7.  Mechanism-based inhibition of human liver microsomal cytochrome P450 1A2 by zileuton, a 5-lipoxygenase inhibitor.

Authors:  Ping Lu; Michael L Schrag; Donald E Slaughter; Conrad E Raab; Magang Shou; A David Rodrigues
Journal:  Drug Metab Dispos       Date:  2003-11       Impact factor: 3.922

Review 8.  Emerging therapies for atopic dermatitis: The prostaglandin/leukotriene pathway.

Authors:  Daniel A Yanes; Joy L Mosser-Goldfarb
Journal:  J Am Acad Dermatol       Date:  2017-12-15       Impact factor: 11.527

9.  A phase 2 randomized, double-blind, placebo-controlled study of the effect of VIA-2291, a 5-lipoxygenase inhibitor, on vascular inflammation in patients after an acute coronary syndrome.

Authors:  Juan Gaztanaga; Michael Farkouh; James H F Rudd; Tilmann M Brotz; David Rosenbaum; Venkatesh Mani; Todd C Kerwin; Rebecca Taub; Jean-Claude Tardif; Ahmed Tawakol; Zahi A Fayad
Journal:  Atherosclerosis       Date:  2015-02-24       Impact factor: 5.162

10.  Inflammation, Cancer and Oxidative Lipoxygenase Activity are Intimately Linked.

Authors:  Rosalina Wisastra; Frank J Dekker
Journal:  Cancers (Basel)       Date:  2014-07-17       Impact factor: 6.639

View more
  1 in total

1.  Exploring the 2'-Hydroxy-Chalcone Framework for the Development of Dual Antioxidant and Soybean Lipoxygenase Inhibitory Agents.

Authors:  Ioanna Kostopoulou; Andromachi Tzani; Nestor-Ioannis Polyzos; Maria-Anna Karadendrou; Eftichia Kritsi; Eleni Pontiki; Thalia Liargkova; Dimitra Hadjipavlou-Litina; Panagiotis Zoumpoulakis; Anastasia Detsi
Journal:  Molecules       Date:  2021-05-08       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.